China, U.S. combined account for approximately 40% of cancer deaths worldwide annually
The "Stabilizing" summit between U.S. President Joe Biden and Chinese President Xi Jinping at the APEC leaders gathering in San Francisco last month has opened a "Small window" between the two for collaboration in the fight against cancer, China policy expert and Australia's Ambassador to the U.S. Kevin Rudd told a forum held at the Asia Society in New York on Friday. "We must acknowledge the delicate nature of US-China relationship and geopolitics and the small window of opportunity opened by the stabilizing APEC summit between Presidents Biden and Xi," said Rudd, who is also president emeritus of the Asia Society. The event was held jointly with the 6th annual symposium organized by the Memorial Sloan Kettering Cancer Center in New York and the Chinese Thoracic Oncology Group of China, which have worked together on cancer research. Fewer than 5% of approximately 20 million cancer patients per year around the world have access to clinical trials of new drugs; increased participation in trials and regulatory harmonization could save 1-2 million lives globally each year, experts say. MORE FOR YOU. "Most notably with China's absence, we miss the leverage of the world's largest cancer patient population accounting for more than 30% of global cancer deaths and as a critical partner in our collective endeavors to accelerate clinical trials," he said. China has the talent and will to boost its role in international collaboration to fight cancer, Wu said. Caroline Kennedy, U.S. Ambassador to Australia, welcomed the donation and lauded the collaboration between the North Shore campus and MSK, drawing inspiration from her late father President John Kennedy's moonshot and noting that this international initiative will contribute to President Joe Biden's Cancer Moonshot that aims to reduce the cancer death rate by half within 25 years and improve the lives of people with cancer and cancer survivors.